Chargement en cours...
β-Blocker pharmacogenetics in heart failure
β-Blockers (metoprolol, bisoprolol, and carvedilol) are a cornerstone of heart failure (HF) treatment. However, it is well recognized that responses to a β-blocker are variable among patients with HF. Numerous studies now suggest that genetic polymorphisms may contribute to variability in responses...
Enregistré dans:
Auteurs principaux: | , |
---|---|
Format: | Artigo |
Langue: | Inglês |
Publié: |
2008
|
Sujets: | |
Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2851851/ https://ncbi.nlm.nih.gov/pubmed/18437562 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10741-008-9094-x |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|